4//SEC Filing
Grayson Paul A. 4
Accession 0001516551-24-000114
CIK 0001516551other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 9:14 PM ET
Size
6.9 KB
Accession
0001516551-24-000114
Insider Transaction Report
Form 4
Grayson Paul A.
Director
Transactions
- Sale
Common Stock
2024-11-15$5.55/sh−307$1,704→ 345,945 total - Sale
Common Stock
2024-11-18$4.99/sh−86,244$430,358→ 259,701 total
Footnotes (2)
- [F1]The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax obligations in connection with the vesting and settlement of performance-based restricted stock units.
- [F2]The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $4.98 to $5.08, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.
Documents
Issuer
Skye Bioscience, Inc.
CIK 0001516551
Entity typeother
Related Parties
1- filerCIK 0001861554
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 9:14 PM ET
- Size
- 6.9 KB